- Home
- ITIC vs BBNX Comparison
ITIC vs BBNX Comparison
Compare ITIC & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITIC | BBNX |
|---|---|---|
| Founded | 1972 | 2015 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 463.3M | 493.1M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | ITIC | BBNX |
|---|---|---|
| Price | $232.45 | $10.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $23.80 |
| AVG Volume (30 Days) | 18.7K | ★ 1.1M |
| Earning Date | 05-04-2026 | 04-21-2026 |
| Dividend Yield | ★ 4.43% | N/A |
| EPS Growth | ★ 13.02 | N/A |
| EPS | ★ 18.57 | N/A |
| Revenue | ★ $272,755,000.00 | N/A |
| Revenue This Year | N/A | $34.90 |
| Revenue Next Year | N/A | $34.63 |
| P/E Ratio | $12.63 | ★ N/A |
| Revenue Growth | ★ 5.60 | N/A |
| 52 Week Low | $190.20 | $8.80 |
| 52 Week High | $288.98 | $32.71 |
Technical Indicators
Market Signals| Indicator | ITIC | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 53.48 | 41.29 |
| Support Level | $230.57 | $9.36 |
| Resistance Level | $249.65 | $11.92 |
| Average True Range (ATR) | 6.07 | 0.83 |
| MACD | -0.72 | -0.13 |
| Stochastic Oscillator | 36.94 | 12.77 |
Price Performance
Historical ComparisonAbout ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The Company has two reportable segments. The Company's primary business activity, and one of its reportable operating segments, is the issuance of residential and commercial title insurance through ITIC and NITIC. The company's second reportable operating segment is providing tax-deferred real property exchange services through its subsidiaries, Investors Title Exchange Corporation (ITEC) and Investors Title Accommodation Corporation (ITAC).
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.